Documents

Ideas Discussions Technicals Forecast Seasonals Options Bonds

Gossamer Bio, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Gossamer Bio, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 05, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 15, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 13, 2025

Earnings release8-K

Q3 2024

Nov 07, 2024

Earnings release8-K

Quarterly report10-Q

Corporate Presentation 2024

Aug 14, 2024

Slides

Q2 2024

Aug 12, 2024

Earnings release8-K

Q1 2024

May 07, 2024

Earnings release8-K

M&A Announcement

May 06, 2024

Press release

Slides

Collaboration with Chiesi Farmaceutici S.p.A. 2024

May 06, 2024

Slides

2023

Q4 2023

Mar 05, 2024

Earnings release8-K

Annual report10-K

Study Update 2023

Dec 18, 2023

Slides

Q3 2023

Nov 09, 2023

Earnings release8-K

Q2 2023

Aug 08, 2023

Earnings release8-K

Status Update 2023

Jul 25, 2023

Slides

Q1 2023

May 09, 2023

Earnings release8-K

Study Result 2023

Dec 06, 2022

Slides

2022

Q4 2022

Mar 17, 2023

Earnings release8-K

Annual report10-K

Q3 2022

Nov 03, 2022

Earnings release8-K

Q2 2022

Aug 09, 2022

Earnings release8-K

Q1 2022

May 10, 2022

Earnings release8-K

2021

Q4 2021

Mar 03, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 08, 2021

Earnings release8-K

Investor Day 2021

Oct 11, 2021

Slides

Q2 2021

Aug 09, 2021

Earnings release8-K

Slides

Q1 2021

May 06, 2021

Earnings release8-K

2020

Q4 2020

Feb 26, 2021

Annual report10-K

2019

Q4 2019

Mar 24, 2020

Annual report10-K

2018

Q4 2018

Mar 22, 2019

Annual report10-K